Header Logo

Connection

BULENT OZPOLAT to Random Allocation

Back to Details
This is a "connection" page, showing publications BULENT OZPOLAT has written about Random Allocation.
BULENT OZPOLAT
Connection Strength
0.039
Random Allocation
  1. Targeting the TMPRSS2/ERG fusion mRNA using liposomal nanovectors enhances docetaxel treatment in prostate cancer. Prostate. 2020 01; 80(1):65-73.
    View in: PubMed
    Score: 0.039
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.